Cargando…

Axillary lymphangioma that developed following COVID-19 vaccination: a case report

BACKGROUND: Extensive vaccination programs are being implemented worldwide for coronavirus disease 2019 (COVID-19). With the spread of vaccination, swelling of the lymph nodes after vaccination is frequently seen. We encountered a patient who developed left axillary lymphadenoma following vaccine ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasa, Soichiro, Inoue, Hiroaki, Inui, Tomohiro, Miyamoto, Naoki, Aoyama, Mariko, Okumura, Kazumasa, Toba, Hiroaki, Yoshida, Takahiro, Tezuka, Miki, Hirose, Chieko, Saijo, Yasuyo, Uehara, Hisanori, Izumori, Ayumi, Takahashi, Masako, Sasa, Mitsunori, Takizawa, Hiromitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263008/
https://www.ncbi.nlm.nih.gov/pubmed/35798903
http://dx.doi.org/10.1186/s40792-022-01488-5
_version_ 1784742629388320768
author Sasa, Soichiro
Inoue, Hiroaki
Inui, Tomohiro
Miyamoto, Naoki
Aoyama, Mariko
Okumura, Kazumasa
Toba, Hiroaki
Yoshida, Takahiro
Tezuka, Miki
Hirose, Chieko
Saijo, Yasuyo
Uehara, Hisanori
Izumori, Ayumi
Takahashi, Masako
Sasa, Mitsunori
Takizawa, Hiromitsu
author_facet Sasa, Soichiro
Inoue, Hiroaki
Inui, Tomohiro
Miyamoto, Naoki
Aoyama, Mariko
Okumura, Kazumasa
Toba, Hiroaki
Yoshida, Takahiro
Tezuka, Miki
Hirose, Chieko
Saijo, Yasuyo
Uehara, Hisanori
Izumori, Ayumi
Takahashi, Masako
Sasa, Mitsunori
Takizawa, Hiromitsu
author_sort Sasa, Soichiro
collection PubMed
description BACKGROUND: Extensive vaccination programs are being implemented worldwide for coronavirus disease 2019 (COVID-19). With the spread of vaccination, swelling of the lymph nodes after vaccination is frequently seen. We encountered a patient who developed left axillary lymphadenoma following vaccine administration. CASE PRESENTATION: The patient was a Japanese woman in her 80 s who had previously undergone surgery for right breast cancer. She received two injections of the Pfizer-BioNTech COVID-19 vaccine in her left arm. Approximately 3 months later, she complained of left axillary swelling, and imaging resulted in a diagnosis of left axillary lymphangioma. In accordance with the patient’s wishes, we performed axillary mass resection. The pathological diagnosis was lymphangioma. CONCLUSION: Our examination findings indicated that congestion of the axillary lymph vessels might have been caused by upper-arm injections of the COVID-19 vaccine.
format Online
Article
Text
id pubmed-9263008
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-92630082022-07-08 Axillary lymphangioma that developed following COVID-19 vaccination: a case report Sasa, Soichiro Inoue, Hiroaki Inui, Tomohiro Miyamoto, Naoki Aoyama, Mariko Okumura, Kazumasa Toba, Hiroaki Yoshida, Takahiro Tezuka, Miki Hirose, Chieko Saijo, Yasuyo Uehara, Hisanori Izumori, Ayumi Takahashi, Masako Sasa, Mitsunori Takizawa, Hiromitsu Surg Case Rep Case Report BACKGROUND: Extensive vaccination programs are being implemented worldwide for coronavirus disease 2019 (COVID-19). With the spread of vaccination, swelling of the lymph nodes after vaccination is frequently seen. We encountered a patient who developed left axillary lymphadenoma following vaccine administration. CASE PRESENTATION: The patient was a Japanese woman in her 80 s who had previously undergone surgery for right breast cancer. She received two injections of the Pfizer-BioNTech COVID-19 vaccine in her left arm. Approximately 3 months later, she complained of left axillary swelling, and imaging resulted in a diagnosis of left axillary lymphangioma. In accordance with the patient’s wishes, we performed axillary mass resection. The pathological diagnosis was lymphangioma. CONCLUSION: Our examination findings indicated that congestion of the axillary lymph vessels might have been caused by upper-arm injections of the COVID-19 vaccine. Springer Berlin Heidelberg 2022-07-08 /pmc/articles/PMC9263008/ /pubmed/35798903 http://dx.doi.org/10.1186/s40792-022-01488-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Case Report
Sasa, Soichiro
Inoue, Hiroaki
Inui, Tomohiro
Miyamoto, Naoki
Aoyama, Mariko
Okumura, Kazumasa
Toba, Hiroaki
Yoshida, Takahiro
Tezuka, Miki
Hirose, Chieko
Saijo, Yasuyo
Uehara, Hisanori
Izumori, Ayumi
Takahashi, Masako
Sasa, Mitsunori
Takizawa, Hiromitsu
Axillary lymphangioma that developed following COVID-19 vaccination: a case report
title Axillary lymphangioma that developed following COVID-19 vaccination: a case report
title_full Axillary lymphangioma that developed following COVID-19 vaccination: a case report
title_fullStr Axillary lymphangioma that developed following COVID-19 vaccination: a case report
title_full_unstemmed Axillary lymphangioma that developed following COVID-19 vaccination: a case report
title_short Axillary lymphangioma that developed following COVID-19 vaccination: a case report
title_sort axillary lymphangioma that developed following covid-19 vaccination: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263008/
https://www.ncbi.nlm.nih.gov/pubmed/35798903
http://dx.doi.org/10.1186/s40792-022-01488-5
work_keys_str_mv AT sasasoichiro axillarylymphangiomathatdevelopedfollowingcovid19vaccinationacasereport
AT inouehiroaki axillarylymphangiomathatdevelopedfollowingcovid19vaccinationacasereport
AT inuitomohiro axillarylymphangiomathatdevelopedfollowingcovid19vaccinationacasereport
AT miyamotonaoki axillarylymphangiomathatdevelopedfollowingcovid19vaccinationacasereport
AT aoyamamariko axillarylymphangiomathatdevelopedfollowingcovid19vaccinationacasereport
AT okumurakazumasa axillarylymphangiomathatdevelopedfollowingcovid19vaccinationacasereport
AT tobahiroaki axillarylymphangiomathatdevelopedfollowingcovid19vaccinationacasereport
AT yoshidatakahiro axillarylymphangiomathatdevelopedfollowingcovid19vaccinationacasereport
AT tezukamiki axillarylymphangiomathatdevelopedfollowingcovid19vaccinationacasereport
AT hirosechieko axillarylymphangiomathatdevelopedfollowingcovid19vaccinationacasereport
AT saijoyasuyo axillarylymphangiomathatdevelopedfollowingcovid19vaccinationacasereport
AT ueharahisanori axillarylymphangiomathatdevelopedfollowingcovid19vaccinationacasereport
AT izumoriayumi axillarylymphangiomathatdevelopedfollowingcovid19vaccinationacasereport
AT takahashimasako axillarylymphangiomathatdevelopedfollowingcovid19vaccinationacasereport
AT sasamitsunori axillarylymphangiomathatdevelopedfollowingcovid19vaccinationacasereport
AT takizawahiromitsu axillarylymphangiomathatdevelopedfollowingcovid19vaccinationacasereport